These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9304673)

  • 1. How will improved forecasts of individual lifetimes affect underwriting?
    MacDonald AS
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1067-75. PubMed ID: 9304673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening and the insurance industry.
    Pokorski R
    Yale J Biol Med; 1991; 64(1):53-7. PubMed ID: 1897262
    [No Abstract]   [Full Text] [Related]  

  • 3. The likely financial effects on individuals, industry and commerce of the use of genetic information.
    Ross T
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1103-6. PubMed ID: 9304677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actuarial considerations on genetic testing.
    Le Grys DJ
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1057-61. PubMed ID: 9304671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing in insurance underwriting: a blessing or a curse? An examination of the tension between economics and equity in using genetic testing in risk classification.
    Anderson MC
    Creighton Law Rev; 1992 Jun; 25(4):1499-535. PubMed ID: 11654461
    [No Abstract]   [Full Text] [Related]  

  • 6. Common themes among different types of insurance.
    Pyeritz RE
    Birth Defects Orig Artic Ser; 1990; 26(2):121-7. PubMed ID: 2151251
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of genetic testing: discrimination in life insurance and future directions.
    Mould A
    J Law Med; 2003 May; 10(4):470-87. PubMed ID: 12852320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of genetic information by private insurers. Genetic advances: the perspective of an insurance medical director.
    Pokorski RJ
    J Insur Med; 1992; 24(1):60-8. PubMed ID: 10148476
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing, adverse selection, and the demand for life insurance.
    Zick CD; Smith KR; Mayer RN; Botkin JR
    Am J Med Genet; 2000 Jul; 93(1):29-39. PubMed ID: 10861679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing genetic tests, surveillance, and preventive medicine under a public health insurance system.
    Filipova-Neumann L; Hoy M
    J Health Econ; 2014 Mar; 34():31-41. PubMed ID: 24463140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic information and insurance: some ethical issues.
    O'Neill O
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1087-93. PubMed ID: 9304675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health insurance problems are not going away.
    Swartz K
    Inquiry; 2000; 37(3):231-3. PubMed ID: 11111281
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic information and life insurance risk classification and antiselection (1).
    Pokorski RJ
    J Insur Med; 1994-1995 Winter; 26(4):413-9. PubMed ID: 10150806
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic testing, life insurance, and adverse selection.
    Harper PS
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1063-6. PubMed ID: 9304672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insurance and late-onset genetic disorders--fears and misunderstandings].
    Prior L
    Praxis (Bern 1994); 2005 Dec; 94(50):2011-4. PubMed ID: 16381454
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic testing for breast and ovarian cancer: implications for life insurance.
    Lemaire J; Subramanian K; Asch DA
    LDI Issue Brief; 2000 Mar; 5(6):1-4. PubMed ID: 12523344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genome analysis--burdens, rights and responsibilities for using genetic knowledge].
    Steinvorth U
    Z Gerontol Geriatr; 1995; 28(5):378-81. PubMed ID: 8528931
    [No Abstract]   [Full Text] [Related]  

  • 18. Panel on legal issues in genetic testing.
    Knoppers BM; Rothstein MA
    J Insur Med; 1993; Suppl B():263-78. PubMed ID: 10146362
    [No Abstract]   [Full Text] [Related]  

  • 19. Underwriting lethal genetic diseases.
    Lowden JA
    J Insur Med; 1998; 30(1):5-11. PubMed ID: 10186441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurance claims due to AIDS plummet to 1988 levels.
    AIDS Policy Law; 1998 Oct; 13(19):4. PubMed ID: 11365952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.